The formation of lymphomas in response to murine leukemia virus (MLV) infection is dependent on MLV persistence and avoidance of immune clearance. Immuno-competent adult mice are typically resistant to the development of lymphoma. In contrast, neonatal animals and immuno-suppressed adults are highly susceptible to MLV-dependent leukemogenesis. We recently determined that Gross murine leukemia virus )G-MLV) induced leukemia in adult when injected intra-thymically. We propose that thymic infection is an essential component of both the abrogation of virus immunity and prolonged exposure to immature thymocytes, the susceptible targets of transformation. Our studies utilize the well characterized molecular clone of G-MLV, GD-17. The thymo- tropism of GD-17 is controlled by unique sequences within the long- terminal leukemogenesis through the creation and in vivo expression of G-MLV based vectors. During the pre-leukemic phase, integrated virus and virus protein expression is detected predominantly in adult medullary thymic adult mice is uniformly linked to inhibition of anti-G-MLV immunity. The proposed studies address the hypothesis that replication of MLV in mTEC is an essential component of immune tolerance, persistent virus infection, and leukemogenesis.
AIM 1 : TO DETERMINE THE ROLE OF EPITHELIAL CELL TROPISM IN THE INHIBITION OF IMMUNE RESPONSES TO MLV AIM 2: TO DETERMINE THE MECHANISM OF TOLERANCE INDUCTION BY THYMO-TROPIC MLV AIM 3: TO DETERMINE THE REQUIREMENTS OF THYMIC G- MLV INFECTION ON IMMUNE TOLERANCE AND LEUKOMOGENESIS

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA077760-03
Application #
6580353
Study Section
Subcommittee G - Education (NCI)
Project Start
2002-03-01
Project End
2003-02-28
Budget Start
Budget End
Support Year
3
Fiscal Year
2002
Total Cost
$103,679
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Mertz, Jennifer A; Kobayashi, Ryuji; Dudley, Jaquelin P (2007) ALY is a common coactivator of RUNX1 and c-Myb on the type B leukemogenic virus enhancer. J Virol 81:3503-13
Seo, Jin; Lozano, Mary M; Dudley, Jaquelin P (2005) Nuclear matrix binding regulates SATB1-mediated transcriptional repression. J Biol Chem 280:24600-9
Bhadra, Sanchita; Lozano, Mary M; Dudley, Jaquelin P (2005) Conversion of mouse mammary tumor virus to a lymphomagenic virus. J Virol 79:12592-6
Czarneski, Jennifer; Rassa, John C; Ross, Susan R (2003) Mouse mammary tumor virus and the immune system. Immunol Res 27:469-80
Broussard, Dana R; Mertz, Jennifer A; Lozano, M et al. (2002) Selection for c-myc integration sites in polyclonal T-cell lymphomas. J Virol 76:2087-99
Zhu, Quan; Dudley, Jaquelin P (2002) CDP binding to multiple sites in the mouse mammary tumor virus long terminal repeat suppresses basal and glucocorticoid-induced transcription. J Virol 76:2168-79
Czarneski, Jennifer; Berguer, Paula; Bekinschtein, Pedro et al. (2002) Neonatal infection with a milk-borne virus is independent of beta7 integrin- and L-selectin-expressing lymphocytes. Eur J Immunol 32:945-56
Dudley, J P; Mertz, J A; Rajan, L et al. (2002) What retroviruses teach us about the involvement of c-Myc in leukemias and lymphomas. Leukemia 16:1086-98
Mertz, J A; Mustafa, F; Meyers, S et al. (2001) Type B leukemogenic virus has a T-cell-specific enhancer that binds AML-1. J Virol 75:2174-84